Replies to post #488863 on NorthWest Biotherapeutics Inc (NWBO)

[HappyLibrarian]

Executing an RS and offering with serious dilution impacts the potential of the company none. It impacts the investors heavily. But I cannot stress this enough. They don’t care about retail investors. They care about institutional investors and that’s what they’re going to attract after the RS. And that’s why there aren’t any institutions invested now.

Well the fact that NWBO is not listed on a major exchange also limits institutional participation though it does not fully explain everything.